A bipartisan trio of senators on Monday introduced a resolution underscoring their opposition to the experiments last year in China that led to the birth of the world’s first genome-edited babies

Quick Read

After a two-year stint running the Food and Drug Administration, Scott Gottlieb has joined the board of directors at Pfizer, giving the world’s largest drug maker crucial insights into the inner workings of the Trump administration as it attempts to contain national angst over the rising cost of medicines

Quick Read

While these findings regarding professionalism are disturbing, they do point toward another way in which fraudulent stem cell clinics can be stopped, said Alan Regenberg, at the Johns Hopkins Berman Institute of Bioethics

Quick Read

Be the first to like. Like Unlike

Quick Read

The goal is to create the continent’s first cross-disciplinary guidelines for collecting, storing and sharing data and specimens

Quick Read

“We can’t stop progress with words on paper,” Denis Rebrikov said, when asked about international efforts to ban such research. Rebrikov spoke about his plans, addressing the scientific arguments against his CCR5 target and specifics about his ultimate aims and the prospect of his controversial experiment moving forward

Quick Read

Backers of Maryland’s stem cell ecosystem hope a federal judge’s ruling last week in a Florida case that the Food and Drug Administration can regulate stem cell treatments is the first step toward protecting their legitimacy. With comments from our Debra Mathews

Quick Read

The agency said two patients received donated stool that had not been screened for drug-resistant germs, leading it to halt clinical trials until researchers prove proper testing procedures are in place

Quick Read